Buscar
Mostrando ítems 1-2 de 2
Leading edge: intratumor delivery of monoclonal antibodies for the treatment of solid tumors
(MDPI, 2023)
Artículo / Artikulua,
Immunotherapies based on immune checkpoint blockade have shown remarkable clinical outcomes and durable responses in patients with many tumor types. Nevertheless, these therapies lack efficacy in most cancer patients, even ...
Mrna vaccines against sars-cov-2: advantages and caveats
(MDPI, 2023)
Artículo / Artikulua,
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection
has constituted a determinant resource to control the COVID-19 pandemic. Since the beginning of
2021, millions of doses have been administered ...